Home > Insider Trading > Filing (0000885590-12-000075)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1453140	Rajiv Silva De	4787 Levy Street Montreal A8 H4R 2P9	Pres & Coo, Specialty Pharm	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2012-11-08	76,344	$25.42	341,561	No	4	M	Direct
Common Stock, No Par Value	Disposition	2012-11-08	76,344	$54.04	265,217	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, No Par Value	Non-Qualified Stock Options (right to purchase)	Disposition	2012-11-08	76,344	$0.00	76,344	$25.42

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
96,136	2012-10-08	2015-11-11	No	4	M	Direct

Footnotes

This number represents the weighted average sale price for all sales of common stock sold by the reporting officer. The actual sale prices range from $54.00 to $54.34. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.
This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.